Program components and results from an organized colorectal cancer screening program using annual fecal immunochemical testing.

Details

Ressource 1Download: Selby_CGH_2020.pdf (1185.39 [Ko])
State: Public
Version: Author's accepted manuscript
License: Not specified
Serval ID
serval:BIB_6354980B3BBF
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Program components and results from an organized colorectal cancer screening program using annual fecal immunochemical testing.
Journal
Clinical gastroenterology and hepatology
Author(s)
Selby K., Jensen C.D., Levin T.R., Lee J.K., Schottinger J.E., Zhao W.K., Corley D.A., Doubeni C.A.
ISSN
1542-7714 (Electronic)
ISSN-L
1542-3565
Publication state
In Press
Peer-reviewed
Oui
Language
english
Notes
Publication types: Journal Article
Publication Status: aheadofprint
Abstract
Programmatic colorectal cancer (CRC) screening increases uptake, but the design and resources utilized for such models are not well known. We characterized program components and participation at each step in a large program that used mailed fecal immunochemical testing (FIT) with opportunistic colonoscopy.
Mixed-methods with site visits and retrospective cohort analysis of 51-75-year-old adults during 2017 in the Kaiser Permanente Northern California integrated health system.
Among 1,023,415 screening-eligible individuals, 405,963 (40%) were up to date with screening at baseline, and 507,401 of the 617,452 not up-to-date were mailed a FIT kit. Of the entire cohort (n=1,023,415), 206,481 (20%) completed FIT within 28 days of mailing, another 61,644 (6%) after a robocall at week 4, and 40,438 others (4%) after a mailed reminder letter at week 6. There were over 800,000 medical record screening alerts generated and about 295,000 FIT kits distributed during patient office visits. About 100,000 FIT kits were ordered during direct-to-patient calls by medical assistants and 111,377 people (11%) completed FIT outside of the automated outreach period. Another 13,560 (1.3%) completed a colonoscopy, sigmoidoscopy, or fecal occult blood test unrelated to FIT. Cumulatively, 839,463 (82%) of those eligible were up to date with screening at the end of the year and 12,091 of 14,450 patients (83.7%) with positive FIT had diagnostic colonoscopy.
The >82% screening participation achieved in this program resulted from a combination of prior endoscopy (40%), large initial response to mailed FIT kits (20%), followed by smaller responses to automated reminders (10%) and personal contact (12%).
Keywords
colorectal cancer screening, fecal immunochemical tests, mailed fecal tests
Pubmed
Open Access
Yes
Create date
09/10/2020 13:26
Last modification date
25/11/2020 7:09
Usage data